SEARCH

SEARCH BY CITATION

References

  • 1
    Hoofnagle JH, di Bisceglie AM. The treatment of chronic viral hepatitis. N Engl J Med 1997; 336:347356.MEDLINE
  • 2
    Carreño V, Castillo I, Molina J, Porres JC, Bartolome J. Long-term follow-up of hepatitis B chronic carriers who responded to interferon therapy. J Hepatol 1992; 15:102106.MEDLINE
  • 3
    Carman WF, Jacyna MR, Hadziyannis S, Karayiannis P, McGarvey MJ, Makris A, Thomas HC. Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection. Lancet 1989; ii:588591.
  • 4
    Brunetto MR, Giarin M, Saracco G, Oliveri F, Calvo P, Capra G, Randone A, et al. Hepatitis B virus unable to secrete e antigen and response to interferon in chronic hepatitis B. Gastroenterology 1993; 105:845850.MEDLINE
  • 5
    Hadziyannis S, Bramou T, Makris A, Moussoulis G, Zignego L, Papaioannou C. Interferon alfa-2b treatment of HBeAg negative/serum HBV DNA positive chronic active hepatitis type B. J Hepatol 1990; 11(Suppl 1):133136.MEDLINE
  • 6
    Fattovich G, Farci P, Rugge M, Brollo L, Mandas A, Pontisso P, Giustina G, et al. A randomized controlled trial of lymphoblastoid interferon-alpha in patients with chronic hepatitis B lacking HBeAg. Hepatology 1992; 15:584589.MEDLINE
  • 7
    López-Alcorocho JM, Bartolomé J, Cotonat T, Carreño V. Efficacy of prolonged interferon-alpha treatment in chronic hepatitis B patients with HBeAb: comparison between 6 and 12 months of therapy. J Viral Hepat 1997; 4(Suppl 1):2732.MEDLINE
  • 8
    Arase Y, Chayama K, Tsubota A, Murashima N, Suzuki Y, Koida I, Kobayashi M, et al. A randomized, double-blind, controlled trial of natural interferon-beta therapy for e-antigen-negative chronic hepatitis B patients with abnormal transaminase levels. J Gastroenterol 1996; 31:559564.MEDLINE
  • 9
    López-Alcorocho JM, Cabrerizo M, Bartolomé J, Cotonat T, Carreño V. Analysis of hepatitis B virus precore variants in hepatitis B e antibody-positive patients treated with prednisone plus interferon. J Viral Hepat 1995; 2:279284.MEDLINE
  • 10
    Tassopoulos NC, Volpes R, Pastore G, Heathcote J, Buti M, Goldin RD, Hawley S, et al. Efficacy of lamivudine in patients with hepatitis B e antigen-negative/hepatitis B virus DNA-positive (precore mutant) chronic hepatitis B. Lamivudine Precore Mutant Study Group. Hepatology 1999; 29:889896.MEDLINE
  • 11
    Hultgren C, Milich DR, Weiland O, Sallberg M. The antiviral compound ribavirin modulates the T helper (Th) 1/Th2 subset balance in hepatitis B and C virus-specific immune responses. J Gen Virol 1998; 79:23812391.MEDLINE
  • 12
    Martín J, Navas S, Quiroga JA, Pardo M, Carreño V. Effects of the ribavirin-interferon alpha combination on cultured peripheral blood mononuclear cells from chronic hepatitis C patients. Cytokine. 1998; 10:635644.MEDLINE
  • 13
    Davis GL, Esteban-Mur R, Rustgi V, Hoefs J, Gordon SC, Trepo C, Shiffman ML, et al. Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group. N Engl J Med 1998; 339:14931499.MEDLINE
  • 14
    Jain S, Thomas HC, Oxford JS, Sherlock S. Trial of ribavirin for the treatment of HBsAg positive chronic liver disease. J Antimicrob Chemother 1978; 4:367373.MEDLINE
  • 15
    Fried MW, Fong TL, Swain MG, Park Y, Beames MP, Banks SM, Hoofnagle JH, et al. Therapy of chronic hepatitis B with a 6-month course of ribavirin. J Hepatol 1994; 21:145150.MEDLINE
  • 16
    Kakumu S, Yoshioka K, Wakita T, Ishikawa T, Takayanagi M, Higashi Y. Pilot study of ribavirin and interferon-beta for chronic hepatitis B. Hepatology 1993; 18:258263.MEDLINE
  • 17
    Scheuer PJ, Davies SE, Dhillon AP. Histopathological aspects of viral hepatitis. J Viral Hepat 1996; 3:277283.MEDLINE
  • 18
    Gerken G, Gomes J, Lampertico P, Colombo M, Rothaar T, Trippler M, Colucci G. Clinical evaluation and applications of the Amplicor HBV Monitor test, a quantitative HBV DNA PCR assay. J Virol Methods 1998; 74:155165.MEDLINE
  • 19
    Oliveri F, Santantonio T, Bellati G, Colombatto P, Mels GC, Carriero L, Dastoli G, et al. Long term response to therapy of chronic anti-HBe-positive hepatitis B is poor independent of type and schedule of interferon. Am J Gastroenterol 1999; 94:13661372.MEDLINE
  • 20
    Tassopoulos NC, Volpes R, Pastore G, Heathcote J, Buti M, Gray DF, Barber J, et al. Post lamivudine treatment follow-up of patients with HBeAg-negative chronic hepatitis B [Abstract]. J Hepatol 1999; 30(Suppl 1):117.
  • 21
    Fattovich G, Giustina G, Schalm SW, Hadziyannis S, Sanchez-Tapias J, Almasio P, Christensen E, et al. Occurrence of hepatocellular carcinoma and decompensation in western European patients with cirrhosis type B. The EUROHEP Study Group on Hepatitis B Virus and Cirrhosis. Hepatology 1995; 21:7782.MEDLINE
  • 22
    Alberti A, Chemello L, Pontisso P, Benvegnù L, Bernardinello E, Cavalletto L. Interferon therapy for chronic viral hepatitis: status report. In: MRizzetto, RHPurcell, JLGerin, GVerme eds. Viral Hepatitis and Liver Disease Turin, Italy: Edizioni Minerva Medica. 1997;727735.
  • 23
    Brunetto MR, Oliveri F, Colombatto P, Capalbo M, Barbera C, Bonino F. Treatment of chronic anti-HBe-positive hepatitis B with interferon-alpha. J Hepatol 1995; 22(Suppl 1):4244.MEDLINE
  • 24
    Lai CL, Chien RN, Leung NW, Chang TT, Guan R, Tai DI, Ng KY, et al. A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group. N Engl J Med 1998; 339:6168.MEDLINE
  • 25
    Lok AS, Chung HT, Liu VW, Ma OC. Long-term follow-up of chronic hepatitis B patients treated with interferon alfa. Gastroenterology 1993; 105:18331838.MEDLINE
  • 26
    Mangia A, Chung YH, Hoofnagle JH, Birkenmeyer L, Mushahwar I, Di Bisceglie AM. Long-term follow-up of patients with chronic hepatitis B treated with interferon alfa. Gastroenterology 1997; 113:16601667.MEDLINE